Incyte | Stammkapital



Ordinary Share Capital Veränderung Datum
Acadia Pharmaceuticals USD 16K 0 2025-03
Agios Pharmaceuticals USD 74K 1000 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amgen USD 33.58B 45M 2025-03
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Exelixis USD 275K 7K 2025-04
Gilead Sciences USD 1000K 0 2024-12
Incyte USD 193K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2025-03
Moderna USD 38.7K 100 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
PTC Therapeutics USD 78K 1000 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Sarepta Therapeutics USD 10K 0 2025-03
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Incyte Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.